CVS Health Corporation (NYSE:CVS) Analyst Ratings and Price Targets

Core Viewpoint - CVS Health Corporation is experiencing a positive outlook from various analysts, with multiple price target upgrades suggesting significant growth potential in the healthcare sector [2][3][4]. Analyst Ratings and Price Targets - Kevin Caliendo from UBS set a price target of $97 for CVS, indicating a potential increase of approximately 24% from its current price of $78.24 [2][6]. - Wolfe Research raised its price target from $85 to $100, reflecting strong market sentiment towards CVS [2][6]. - Leerink Partners increased their price objective from $86 to $95, maintaining an "outperform" rating [3]. - Evercore ISI also raised their price target from $85 to $95, assigning an "outperform" rating [3]. Market Sentiment and Stock Performance - Despite the positive outlook from several analysts, Zacks Research downgraded CVS from a "strong-buy" to a "hold" rating, indicating some caution in the market [4][6]. - The stock's current price of $78.24 reflects a 2.23% increase, with a trading volume of 12.58 million shares on the NYSE [4]. - CVS's market capitalization is approximately $99.32 billion, highlighting its significant presence in the healthcare industry [5]. Stock Volatility - The stock has fluctuated between a low of $78.22 and a high of $80.50 today, with a 52-week range of $43.56 to $85.15, indicating dynamic market conditions [5].